<![CDATA[TIL Cell Therapy in HIV Positive Patient With Metastatic Melanoma: Case Report]]>

Data ReadoutpositiveTIL therapyPositive

AI Analysis

Summary

Researchers reported the first known case of TIL (tumor-infiltrating lymphocyte) cell therapy in a patient with well-controlled HIV and metastatic melanoma, demonstrating the potential application of this immunotherapy in HIV-positive cancer patients.

Clinical Trial Data

Patients

Outcome Details

First known case of TIL therapy in HIV-positive patient with well-controlled HIV and metastatic melanoma

Importance:4/10

Sentiment:

0.60

TIL cell therapymelanomaHIVcase reportimmunotherapy

Related Companies

$TRAX

Read the original article

Published by Cancer Network on August 3, 2026 12:39 PM

Read Original